Inhibition of the phosphatidylinositol 3-kinase pathway contributes to HT29 and Caco-2 intestinal cell differentiation

Gastroenterology

Volumn 120, Issue 6, 2001, Pages 1381-1392

  Wang, Qingding ^a   Wang, Xiaofu ^a   Hernandez, Ambrosio ^a   Kim, Sunghoon ^a   Evers, B Mark ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BUTYRIC ACID; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P85; SUCRASE; WORTMANNIN;

ARTICLE; CELL DIFFERENTIATION; CELL STRAIN CACO 2; CELL STRAIN HT29; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME INHIBITION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTESTINE CELL; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0035045908     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.24044     Document Type: Article

References (59)

1. Growth and development of the gastrointestinal tract
2. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types
3. Studies of intestinal stem cells using normal, chimeric, and transgenic mice
4. Derivation of mouse intestinal crypts from single progenitor cells
5. Differentiation of intestinal epithelial cells: Lessons from the study of intestine-specific gene expression
6. Phosphoinositide kinases
7. Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation
8. Signalling through phosphoinositide 3-kinases: The lipids take centre stage
9. The phosphatidylinositol 3-kinase alpha is required for DNA synthesis induced by some, but not all, growth factors
10. Activated phosphatidylinositol 3-kinase and Akt kinase promote survival of superior cervical neurons
11. Wortmannin causes mistargeting of procathepsin D. Evidence for the involvement of a phosphatidylinositol 3-kinase in vesicular transport to lysosomes
12. Phosphatidylinositol 3-kinase is required for the formation of constitutive transport vesicles from the TGN
13. An essential role of phosphatidylinositol 3-kinase in myogenic differentiation
14. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras
15. Increased levels of phosphatidylinositol 3-kinase activity in colorectal tumors
16. Posttranscriptional control of adipocyte differentiation through activation of phosphoinositide 3-kinase
17. Rapid lamellipodia formation in nerve growth factor-stimulated PC12 cells is dependent on Rac and PI3K activity
18. Inhibition of the phosphatidylinositol 3-kinase/p70(S6)-kinase pathway induces B16 melanoma cell differentiation
19. Phosphatidylinositol 3-kinase is a negative regulator of cellular differentiation
20. Identification of a candidate tumor suppressor gene at 10q23.3 that is mutated in multiple advanced cancers, MMAC1
21. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta
22. PTEN: A tumour suppressor that functions as a phospholipid phosphatase
23. Restoration of wild-type PTEN expression leads to apoptosis, induces differentiation, and reduces telomerase activity in human glioma cells
24. The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes
25. The multiple roles of PTEN in tumor suppression
26. PTEN is essential for embryonic development and tumour suppression
27. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice
28. Mutation of PTEN/Mmac1 in mice causes neoplasia in multiple organ systems
29. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
30. Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines
31. Differential modulation of human (Caco-2) colon cancer cell line phenotype by short chain fatty acids
32. Caco-2 intestinal cell differentiation is associated with G1 arrest and suppression of CDK2 and CDK4
33. Caco-2 cells express a combination of colonocyte and enterocyte phenotypes
34. Neurite outgrowth of PC12 cells is suppressed by wortmannin, a specific inhibitor of phosphatidylinositol 3-kinase
35. Adenovirus-mediated delivery of the PTEN gene inhibits cell growth by induction of apoptosis in endometrial cancer
36. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
37. Downregulation of mitogen-activated protein kinases in human colon cancers
38. The neurotensin gene is a downstream target for Ras activation
39. A one-step ultramicro method for the assay of intestinal disaccharidases
40. Characterization of promoter elements required for cell-specific expression of the neurotensin/neuromedin N gene in a human endocrine cell line
41. Induced differentiation in HT29, a human colon adenocarcinoma cell line
42. Mitogen-activated protein kinase activation regulates intestinal epithelial differentiation
43. Na-K-2Cl cotransporter gene expression and function during enterocyte differentiation. Modulation of Cl-secretory capacity by butyrate
44. Cellular growth state differentially regulates enterocyte gene expression in butyrate-treated HT-29 cells
45. Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells
46. Butyrate-induced differentiation of Caco-2 cells is associated with apoptosis and early induction of p21Waf1/Cip1 and p27Kip1
47. Butyrate inhibits colon carcinoma cell growth through two distinct pathways
48. Human colon carcinoma cell lines as in vitro models for the study of intestinal cell differentiation
49. Effect of short-chain fatty acids on paracellular permeability in Caco-2 intestinal epithelium model
50. Comparison of the effect of different short chain fatty acids on the growth and differentiation of human colonic carcinoma cell lines in vitro
51. Dedifferentiation of adenocarcinomas by activation of phosphatidylinositol 3-kinase
52. Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells
53. Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kgamma
54. PTEN gene and integrin signaling in cancer
55. Involvement of PTEN mutations in the genetic pathways of colorectal cancerogenesis
56. PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway
57. Enterocytic differentiation of the human Caco-2 cell line correlates with alterations in integrin signaling
58. Requirement of the MAP kinase cascade for cell cycle progression and differentiation of human intestinal cells
59. Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells